Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance

Stock Information for Assertio Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.